|Articles|September 2, 2014
Applied Clinical Trials Editorial Advisory Board and Clinical Trials Professionals Discuss Importance of DIA
Advertisement
Nancy Dreyer, PhD, MPH, FISPe, discusses the importance of DIA to the industry.
Stewart Geary, MD, discusses how global drug development benefits from DIA.
Michael R. Hamrell, PhD, discusses the impact of DIA on professional development.
Moe Alsumidae discusses how DIA's neutral platform grows industry collaboration and communication.
Tim Callahan, PhD, discusses the scientific benefit of DIA
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
